PWJA Holds 26th Annual Convention-Seminar

June 3, 2021

The Philippine Women Judges Association (PWJA) held its 26th Annual, and first virtual, Convention-Seminar on June 2-3, 2021.

With the theme A Call for PWJA: Resiliency Amidst Pandemic, the PWJA provided lectures for its members focusing on timely issues such as the conduct of videoconferencing trials and the vaccination program against COVID-19.

Among these lectures were Surviving the Pandemic: The Practical Science Behind the COVID-19 Vaccine by Department of Health Undersecretary Dr. Maria Rosario Singh-Vergeire; Virtual Court Hearings and Online Mediation: Boon or  Bane? by Court of Appeals Justice Maria Filomena D. Singh; and Face to Face Models of Adaptation – Best Court Practices to Face the COVID-19 Challenge by World Health Organization Regional Office for the Western Pacific Consultant Dr. Albert Francis E. Domingo.

There was also an “OCA (Office of the Court Administrator) Hour” where concerns of lower court judges were addressed by Court Administrator Jose Midas P. Marquez and other OCA officials.

In her message PWJA President Senior Associate Justice Estela M. Perlas- Bernabe, thanked all PWJA members for their support especially for the programs extending help to their fellow judiciary workers during this time of pandemic. She also noted that the PWJA last year launched its website,, and has inked a memorandum of agreement with a health care provider for its members and their dependents.

Chief Justice Alexander G. Gesmundo keynoted the first day of the two- day convention where he had encouraged the PWJA members to expertly utilize technology for an effective and efficient administration of justice.

Chief Justice Gesmundo also acknowledged Senior Associate Justice Perlas-Bernabe’s hard work in securing the vaccines for the Judiciary, and in upgrading the category as vaccine recipients of the judiciary workers. Upon her initiative, the National Task Force Against Covid-19 has granted the Court’s request for inclusion in the priority population group A4 (category A4) of the Philippine Deployment and Vaccination Plan for COVID-19 Vaccines. ###